| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |